Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years and Over|
- - PATIENT: Carry a diagnosis of BCR-ABL-negative MPN or CML.
- - PATIENT: Have an estimated life expectancy of at least 6 months, assessed by principal investigator or treating investigator.
- - PATIENT: Be able to speak and read English.
- - PATIENT: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report) - PATIENT: Have daily access to a mobile phone capable of receiving text messages, as determined by a study investigator.
- - PATIENT: Be able to provide informed consent.
- - CAREGIVER: Be a spouse/partner, other family member, or a close friend of a BCR-ABL-negative patient who consented to participate in the Being Present-MPN study.
- - CAREGIVER: Be able to speak and read English.
- - CAREGIVER: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report) - CAREGIVER: Have access to a mobile phone capable of receiving text messages, as determined by a study investigator.
- - CAREGIVER: Be able to provide informed consent.
- - PATIENT: Have had their BCR-ABL-negative MPN transform into acute leukemia.
- - PATIENT: Have had their CP-CML transform into blast phase.
- - PATIENT: Be post-allogeneic stem cell transplantation.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
|University of California, San Francisco|
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Kelly Schoenbeck, MD|
|Principal Investigator Affiliation||University of California, San Francisco|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
|Myeloproliferative Neoplasm, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia|
- I. To tailor the Being Present intervention to BCR-ABL-negative MPN and CP-CML patients.
- II. To determine the feasibility of an 8-week web-based mindfulness meditation program with live webinars among BCR-ABL-negative MPN patients and their caregivers, and CP-CML patients on tyrosine kinase inhibitors (TKIs), and CP-CML patients in treatment-free remission (TFR).
- III. To determine the acceptability of an 8-week web-based mindfulness meditation program with live webinars among BCR-ABL-negative MPN patients and their caregivers, CP-CML patients on TKIs, CP-CML patients on TKIs, and CP-CML patients in TFR.
- I. To evaluate the preliminary efficacy of the intervention.
- I. To evaluate for differences in the feasibility and acceptability of an 8-week web-based mindfulness meditation program with live webinars: Ia.
- II. To evaluate for differences in the preliminary efficacy an 8-week web-based mindfulness meditation program with live webinars: IIa.
Experimental: Being Present (Supportive Care)
Patients and caregivers receive Being Present intervention consisting of online audio-based mindfulness meditation exercise over 15 minutes at least 5 times per week, daily meditation reminders, and online webinars over 30-60 minutes every week.
Behavioral: - Online Mindfulness Meditation
Complete online audio-based mindfulness meditation exercises
Other: - Internet-Based Webinars
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Site by: Kaleidoscopic